Multilabel classification for exploiting cross-resistance information in HIV-1 drug resistance prediction

Bioinformatics

Volumn 29, Issue 16, 2013, Pages 1946-1952

  Heider, Dominik ^a,b   Senge, Robin ^a   Cheng, Weiwei ^a   Hüllermeier, Eyke ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; REVERSE TRANSCRIPTASE, HUMAN IMMUNODEFICIENCY VIRUS 1; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ANTIVIRAL RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTATION; SEQUENCE ANALYSIS; VIRUS REPLICATION; DRUG EFFECTS;

ANTI-HIV AGENTS; DRUG RESISTANCE, VIRAL; HIV REVERSE TRANSCRIPTASE; HIV-1; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ANALYSIS; VIRUS REPLICATION;

EID: 84880999235     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btt331     Document Type: Article

References (24)

1. Antinori, A. et al. (2006) Antiviral efficacy and genotypic resistance patterns of combination therapy with stavudine/tenofovir in highly active antiretroviral therapy experienced patients. Antivir. Ther., 11, 233-243.
2. Breiman, L. (2001) Random forests. Mach. Learn., 45, 5-32.
3. Calle, M.L. and Urrea, V. (2010) Letter to the editor: stability of random forest importance measures. Brief. Bioinform., 12, 86-89.
4. Chowriappa, P. et al. (2008) Protein structure classification based on conserved hydrophobic residues. IEEE/ACM Trans. Comput. Biol. Bioinform., 6, 639-51.
5. Dembczyński, K. et al. (2010) Bayes optimal multilabel classification via probabilistic classifier chains. In ICML, pages 279-286.
6. Dybowski, J.N. et al. (2010) Prediction of co-receptor usage of HIV-1 from genotype. PLoS Comput. Biol., 6, e1000743.
7. Garcia-Lerma, J.G. et al. (2003) A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. J. Virol., 77, 5685-5693.
8. Gouy, M. et al. (2010) SeaView version 4: A multiplatform graphical user interface for sequence alignment and phylogenetic tree building. Mol. Biol. Evol., 27, 221-224.
9. Heider, D. and Hoffmann, D. (2011) Interpol: an R package for preprocessing of protein sequences. BioData Min., 4, 16.
10. Heider, D. et al. (2009) A computational approach for the identification of small GTPases based on preprocessed amino acid sequences. Technol. Cancer Res. Treat., 8, 333-342.
11. Heider, D. et al. (2010) Predicting Bevirimat resistance of HIV-1 from genotype. BMC Bioinformatics, 11, 37.
12. Johnson, V.A. et al. (2011) 2011 update of the drug resistance mutations in HIV-1. Top. Antivir. Med., 19, 156-164.
13. Kierczak, M. et al. (2009) A rough set-based model of HIV-1 reverse transcriptase resistome. Bioinform. Biol. Insights, 3, 109-127.
14. Kierczak, M. et al. (2010) Computational analysis of molecular interaction networks underlying change of HIV-1 resistance to selected reverse transcriptase inhibitors. Bioinform. Biol. Insights, 4, 137-146.
15. Kyte, J. and Doolittle, R. (1982) A simple method for displaying the hydropathic character of a protein. J. Mol. Biol., 157, 105-132.
16. Lafeuillade, A. and Tardy, J.C. (2003) Stavudine in the face of cross-resistance between HIV-1 nucleoside reverse transcriptase inhibitors: a review. AIDS Rev., 5, 80-86.
17. Pennings, P.S. (2012) Standing genetic variation and the evolution of drug resistance in HIV. PLoS Comput. Biol., 8, e1002527.
18. Read, J. et al. (2011) Classifier chains for multi-label classification. Mach. Learn., 85, 333-359.
19. Rhee, S.Y. et al. (2006) Genotypic predictors of human immunodeficiency virus type 1 drug resistance. Proc. Natl. Acad. Sci. USA, 103, 17355-17360.
20. Senge, R. et al. (2013) On the problem of error propagation in classier chains for multi-label classification. In: Schmidt-Thieme, L. and Spiliopoulou, M. (eds) Data Analysis, Machine Learning and Knowledge Discovery. Proceedings of the 36th Annual Conference of the German Classification Society. Springer, Hildesheim, Germany.
21. Sirivichayakul, S. et al. (2003) Nucleoside analogue mutations and Q151M in HIV-1 subtype A/E infection treated with nucleoside reverse transcriptase inhibitors. AIDS, 17, 1889-1896.
22. Stürmer, M. et al. (2007) Quadruple nucleoside therapy with zidovudine, lamivudine, abacavir and tenofovir in the treatment of HIV. Antivir. Ther., 12, 695-703.
23. Tripathi, K. et al. (2012) Stochastic simulations suggest that HIV-1 survives close to its error threshold. PLoS Comput. Biol., 8, e1002684.
24. Tsoumakas, G. and Katakis, I. (2007) Multi label classification: an overview. Int. J. Data Warehouse Min., 3, 1-13.